03 October 2023 Tapestri GE DNA, GE DNA + Protein Pipeline v1.0

  • Updated
  • Rapidly characterize gene-edited drug products
  • Identify on- and off-target editing, as well as the zygosity of edits.
  • Measure co-occurring edits in a single cell
  • Gain deeper multi-omic analysis through co-measuring editing and cell-surface protein expression in the same cells
  • First-in-class analytical solution quickly detects intended and unintended edits in engineered cells at single-cell resolution, enabling safer therapies and better disease modeling.
  • Single-cell analysis and data reporting is automated– saving you hours of bioinformatics work.
Share this article:

Was this article helpful?

0 out of 0 found this helpful

Have more questions? Submit a request

Related articles